| Thailandia | Turchia | Austria | |
| Chemioterapia per la leucemia | da $15,000 / 510,000฿ | da $8,000 / 272,000฿ | da $15,000 / 510,000฿ |
Bookimed non aggiunge costi extra ai prezzi di Chemioterapia per la leucemia. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica per la tua Chemioterapia per la leucemia al tuo arrivo.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali in Chemioterapia per la leucemia e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di Chemioterapia per la leucemia.
Giorno 1
Giorno 2
Giorno 3
Giorno 4 - Giorno 10 (Giorni di trattamento)
Giorno 11 - Giorno 14 (Post-trattamento)
Settimana 2 - Settimana 4 (Riabilitazione)
Si prega di notare che la cronologia di recupero di ogni paziente può variare in base alle circostanze individuali e alla gravità della malattia.
Dr. Kodchanut Litleaungdej is a hematologist at Intrarat Hospital in Bangkok. She specializes in the treatment of leukemia, myeloma, and complex lymphomas. Dr. Litleaungdej co-authored a clinical risk prediction model for cancer-associated venous thromboembolism. She graduated with second-class honors from Naresuan University before completing a hematology fellowship at Thammasat University.
Dr. Nichakorn Seehirunwong is a diagnostic radiologist at Intrarat Hospital in Bangkok. She specializes in interpreting medical imaging results and informing complex treatment plans. Dr. Seehirunwong earned her medical degree from the Prince of Songkla University. She also completed her diagnostic radiology certification at the same institution.
Il medico è un oncologo e oncoematologo esperto con una specializzazione nei trapianti di midollo osseo. Hanno dedicato la loro carriera all'avanzamento dei trattamenti in oncologia e ematologia, concentrandosi su terapie innovative e cura del paziente. Il medico ha contribuito in modo significativo alla ricerca clinica nel suo campo, migliorando i protocolli di trattamento e i risultati per i pazienti. Il loro lavoro nel trapianto di midollo osseo è particolarmente degno di nota, con una comprovata esperienza di procedure di successo e tassi di sopravvivenza migliorati per i pazienti.<\/p>
Leading Thai hospitals like Bumrungrad International and Bangkok Hospital feature dedicated international support teams for chemotherapy. These centers provide GHA and JCI-accredited care, combining oncology expertise with concierge services, multilingual coordination, and visa assistance specifically for leukemia patients from over 190 countries.
Bookimed Expert Insight: While many focus on Bangkok, Bangkok Hospital Pattaya offers JCI-accredited oncology support for those preferring a quieter recovery. Its international team manages over 400,000 patients annually, often providing faster appointment scheduling for chemotherapy than the more crowded metropolitan hubs.
Patient Consensus: Patients value the 24/7 translation support and seamless airport-to-clinic transfers. Many recommend contacting international desks directly to secure leukemia-specific price quotes and coordinator introductions before traveling.
Thai hospitals coordinate international leukemia care through dedicated centers that integrate medical, logistical, and administrative support. Multidisciplinary tumor boards featuring hematologists, like those at Bumrungrad International Hospital, design personalized chemotherapy protocols while coordinators manage JCI-accredited safety standards, visa extensions, and multilingual communication for patients from over 190 countries.
Bookimed Expert Insight: The depth of coordination at top Bangkok facilities is driven by massive international volume, with some centers serving over 500,000 foreign patients annually. This scale allows clinics to employ specialized oncology case managers who function as a single point of contact. Data shows these coordinators are essential for navigating the 4-week inpatient induction phase typical for leukemia, where medical and visa timelines must align perfectly.
Patient Consensus: Patients value the one-stop coordination where chemotherapy cycles are synchronized with hotel stays and daily nurse check-ins. Many highlight that having Western-trained, English-speaking oncologists significantly reduces the emotional stress of managing a complex diagnosis abroad.
Thailand provides high-quality leukaemia care through JCI-accredited hospitals specialising in haematology and oncology. These facilities offer chemotherapy and bone marrow transplants using pathology and diagnostic tools. International patients benefit from immediate treatment access. This helps them avoid long wait times common in Western public health systems.
Bookimed Expert Insight: Thailand’s private sector is geared toward international patients. Bumrungrad reports that 50% of its 1,000,000 annual patients arrive from abroad. This high volume means nursing teams and pathology labs are highly experienced. They specialise in managing leukaemia complications like neutropenic fever and urgent transfusions.
Patient Consensus: Real experiences in Thailand centre on the efficiency of private tertiary hospitals. Patients also highlight the importance of identifying a dedicated haematology team. They recommend confirming that pathology results and medical records will be shared digitally. This helps their Australian oncologists provide future support.
Leading leukaemia specialists in Thailand work mostly in JCI-accredited haematology centres in Bangkok. Top experts include Dr Surasit Saleh Issarachai and Dr Narin Voravud at Bumrungrad International Hospital. Dr Kodchanut Litleaungdej at Intrarat Hospital is another Thai Board-certified specialist. These doctors specialise in intensive chemotherapy and bone marrow transplants.
Bookimed Expert Insight: While Bangkok is the primary hub, Bumrungrad International Hospital is a standout for Australians. Data reveals it has a 50% international patient share and a Newsweek world ranking. Their haematologists manage rare leukaemia subtypes more often than most general oncologists.
Patient Consensus: Patients suggest asking haematologists about their case volume for your specific leukaemia subtype. They also recommend checking that the hospital has dedicated infectious disease and transfusion services.
Top hospitals for leukaemia treatment in Bangkok include Bumrungrad International Hospital and Bangkok Hospital. Both hold JCI accreditation. These facilities provide haematology services, including chemotherapy and bone marrow transplants. Specialist centres like Intrarat Hospital also offer dedicated haematology-oncology care with Thai Board-certified specialists.
Bookimed Expert Insight: Bookimed data shows that 50% of patients at Bangkok’s leading hospitals are international. This high volume means facilities like Bumrungrad have efficient systems for English-speaking patients. For Australians, this often includes telehealth follow-up options and medical records provided in English for their GP.
Patient Consensus: Patients recommend choosing large private hospitals in Thailand with on-site blood transfusion support. They also suggest hospitals with rapid pathology turnaround. Patients prefer securing a named specialist to lead the treatment plan for better continuity between chemotherapy cycles.
Leukaemia chemotherapy in Thailand typically starts with a four-week intensive induction phase as an inpatient. Depending on the leukaemia type, the full treatment course can span one to three years. Major Bangkok hospitals specialise in these long-term protocols for international patients.
Bookimed Expert Insight: While chemotherapy starts at $2,000, full induction cycles in Thailand range from $15,000 to $22,000. JCI-accredited centres like Bumrungrad International Hospital serve over 1 million patients annually. These hospitals provide dedicated visa support for 12-month care plans.
Patient Consensus: Patients find the 90-day medical visa essential for starting induction therapy in Thailand. They appreciate that Bangkok hospitals coordinate accommodation and interpreters for the long maintenance phases.
CAR T-cell therapy is available in Thailand for leukaemia and lymphoma patients. Major Bangkok centres provide this immunotherapy. These include Chulalongkorn University and specialised private hospitals. Access occurs through clinical trials or compassionate use programs. These programs treat specific haematological malignancies in both children and adults.
Bookimed Expert Insight: Chemotherapy for leukaemia typically costs between $15,000 and $22,000 in Thailand. However, CAR T-cell therapy is a separate, higher-tier investment. Some Bangkok hospitals now offer telehealth follow-ups for international patients. This is vital for monitoring cytokine release syndrome after returning to Australia.
Patient Consensus: Patients suggest confirming whether the centre treats your specific leukaemia subtype before travelling. They also recommend asking about the vein-to-vein time for manufacturing cells while staying abroad.
Specialised cancer centres treat leukaemia in regional hubs like Pattaya, Chon Buri, and Phuket. Facilities like Bangkok Hospital Pattaya and Cancer Alliance Hospital provide haematology and chemotherapy. These centres maintain international accreditations, such as Joint Commission International (JCI), for high-level oncology care outside the capital.
Bookimed Expert Insight: Bangkok is the primary hub, but regional centres like Bangkok Hospital Pattaya handle 400,000+ patients annually. Board-certified haematologists like Dr Kodchanut Litleaungdej practise in areas such as Hua Hin. This confirms that tertiary-level blood cancer expertise is accessible in major coastal cities.
Patient Consensus: Patients suggest confirming a specialist haematologist-oncologist is on-site rather than a general specialist. They report that regional tertiary hospitals in Thailand effectively manage chemotherapy and blood transfusions in-house.